Childhood obesity and environmental chemicals

Mount Sinai Journal of Medicine

Volumn 78, Issue 1, 2011, Pages 22-48

  La Merrill, Michele ^a   Birnbaum, Linda S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

environmental exposure; growth and development; obesity

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ARIPIPRAZOLE; CHLORPHENOTANE; CIGARETTE SMOKE; DIETHYLSTILBESTROL; DIOXIN; ENVIRONMENTAL CHEMICAL; HEXACHLOROBENZENE; HEXACHLOROCYCLOHEXANE; LEAD; OLANZAPINE; ORGANOCHLORINE PESTICIDE; ORGANOTIN COMPOUND; PERFLUOROALKYL DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHTHALIC ACID; PIOGLITAZONE; POLYBROMINATED DIPHENYL ETHER; QUETIAPINE; RISPERIDONE; ROSIGLITAZONE; SURFACTANT; TROGLITAZONE; UNCLASSIFIED DRUG;

AIR POLLUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; DRUG HALF LIFE; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; EXHAUST GAS; FAT MASS; HEALTH SURVEY; HUMAN; LEAD POISONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POLLUTANT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SIDE EFFECT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN;

ADOLESCENT; CHILD; ENVIRONMENTAL POLLUTANTS; HUMANS; OBESITY;

EID: 79251495107     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20229     Document Type: Article

References (189)

1. Wang Y, Lobstein T., Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1 (1): 11-25.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA Apr 5 2006; 295 (13): 1549-1555.
3. Bolding J, Wratchford T, Perkins K, Ogershok P., Prevalence of obesity, acanthosis nigricans and hyperinsulinemia in an adolescent clinic. W V Med J May-Jun 2005; 101 (3): 112-115.
4. Stewart ST, Cutler DM, Rosen AB., Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med Dec 3 2009; 361 (23): 2252-2260.
5. Carmichael AR., Obesity and prognosis of breast cancer. Obes Rev Nov 2006; 7 (4): 333-340.
6. Shaw J., Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes Dec 2007; 8 (Suppl 9): 7-15.
7. Cawley J, Meyerhoefer C., The medical care costs of obesity: an instrumental variables approach: National Bureau of Economic Research; 2010.
8. Newbold RR., Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) Jul-Sep 2010; 9 (3): 206-217.
9. Grun F, Blumberg B., Endocrine disrupters as obesogens. Mol Cell Endocrinol May 25 2009; 304 (1-2): 19-29.
10. Roseboom T, de Rooij S, Painter R., The Dutch famine and its long-term consequences for adult health. Early Hum Dev Aug 2006; 82 (8): 485-491.
11. Schack-Nielsen L, Michaelsen KF, Gamborg M, Mortensen EL, Sorensen TI., Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood. Int J Obes (Lond) Jan 2010; 34 (1): 67-74.
12. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG Apr 2010; 117 (5): 575-584.
13. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ., Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature Oct 21 2010; 467 (7318): 963-966.
14. Huang JS, Lee TA, Lu MC., Prenatal programming of childhood overweight and obesity. Matern Child Health J Sep 2007; 11 (5): 461-473.
15. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ., Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care Sep 2007; 30 (9): 2287-2292.
16. Ong KK., Early determinants of obesity. Endocr Dev 2010; 19: 53-61.
17. Saenger P, Czernichow P, Hughes I, Reiter EO., Small for gestational age: short stature and beyond. Endocr Rev Apr 2007; 28 (2): 219-251.
18. Weiderpass E, Braaten T, Magnusson C, et al., A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev Jul 2004; 13 (7): 1121-1127.
19. McMillen IC, Robinson JS., Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev Apr 2005; 85 (2): 571-633.
20. Birnbaum LS, Fenton SE., Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect Apr 2003; 111 (4): 389-394.
21. Salsberry PJ, Reagan PB., Taking the long view: the prenatal environment and early adolescent overweight. Res Nurs Health Jun 2007; 30 (3): 297-307.
22. Montgomery SM, Ekbom A., Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ Jan 5 2002; 324 (7328): 26-27.
23. Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN., Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol Jan 17 2007.
24. Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE., Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol May 25 2009; 304 (1-2): 97-105.
25. Huang RC, Mori TA, Burke V, et al., Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care Apr 2009; 32 (4): 695-701.
26. Spathopoulos D, Paraskakis E, Trypsianis G, et al., The effect of obesity on pulmonary lung function of school aged children in Greece. Pediatr Pulmonol Mar 2009; 44 (3): 273-280.
27. Biro FM, Galvez MP, Greenspan LC, et al., Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics Sep 2010; 126 (3): e583-590.
28. Wolff MS, Britton JA, Teitelbaum SL, et al., Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev Sep 2005; 14 (9): 2224-2236.
29. Emond C, Birnbaum LS, DeVito MJ., Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD. Environ Health Perspect Sep 2006; 114 (9): 1394-1400.
30. Michalek JE, Tripathi RC., Pharmacokinetics of TCDD in veterans of Operation Ranch Hand: 15-year follow-up. J Toxicol Environ Health A Jul 23 1999; 57 (6): 369-378.
31. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P., Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev Mar 2000; 9 (3): 271-277.
32. Yoo JS, Norman JO, Busbee DL., Benzo[a]pyrene uptake by serum lipids: correlation with triglyceride concentration. Proc Soc Exp Biol Med Dec 1984; 177 (3): 434-440.
33. Leighty EG, Fentiman AF, Jr,., Thompson RM. Conjugation of fatty acids to DDT in the rat: possible mechanism for retention. Toxicology 1980; 15 (2): 77-82.
34. Zaleski J, Kwei GY, Thurman RG, Kauffman FC., Suppression of benzo[a]pyrene metabolism by accumulation of triacylglycerols in rat hepatocytes: effect of high-fat and food-restricted diets. Carcinogenesis Nov 1991; 12 (11): 2073-2079.
35. Van den Berg M, Birnbaum LS, Denison M, et al., The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci Oct 2006; 93 (2): 223-241.
36. Patandin S, Koopman-Esseboom C, de Ridder MA, Weisglas-Kuperus N, Sauer PJ., Effects of environmental exposure to polychlorinated biphenyls and dioxins on birth size and growth in Dutch children. Pediatr Res Oct 1998; 44 (4): 538-545.
37. Hunt LP, Ford A, Sabin MA, Crowne EC, Shield JP., Clinical measures of adiposity and percentage fat loss: which measure most accurately reflects fat loss and what should we aim for? Arch Dis Child May 2007; 92 (5): 399-403.
38. Cole TJ, Faith MS, Pietrobelli A, Heo M., What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? Eur J Clin Nutr Mar 2005; 59 (3): 419-425.
39. Karmaus W, Osuch JR, Eneli I, et al., Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med Mar 2009; 66 (3): 143-149.
40. Gladen BC, Ragan NB, Rogan WJ., Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr Apr 2000; 136 (4): 490-496.
41. Verhulst SL, Nelen V, Hond ED, et al., Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect Jan 2009; 117 (1): 122-126.
42. Dhooge W, Den Hond E, Koppen G, et al., Internal exposure to pollutants and body size in Flemish adolescents and adults: associations and dose-response relationships. Environ Int May 2010; 36 (4): 330-337.
43. Uemura H, Arisawa K, Hiyoshi M, et al., Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan's general population. Environ Health Perspect Apr 2009; 117 (4): 568-573.
44. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR, Jr,. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia Sep 2007; 50 (9): 1841-1851.
45. Ha MH, Lee DH, Jacobs DR., Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect Aug 2007; 115 (8): 1204-1209.
46. Chang JW, Chen HL, Su HJ, Liao PC, Guo HR, Lee CC., Dioxin exposure and insulin resistance in Taiwanese living near a highly contaminated area. Epidemiology Jan 2010; 21 (1): 56-61.
47. Lilienthal H, Hack A, Roth-Harer A, Grande SW, Talsness CE., Effects of developmental exposure to 2,2,4,4,5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environ Health Perspect Feb 2006; 114 (2): 194-201.
48. La Merrill M, Baston DS, Denison MS, Birnbaum LS, Pomp D, Threadgill DW., Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat. Am J Physiol Endocrinol Metab 2009; 296 (1): E203-210.
49. La Merrill M, Kuruvilla BS, Pomp D, Birnbaum LS, Threadgill DW., Dietary fat alters body composition, mammary development and P450 induction following maternal TCDD exposure in DBA/2J mice with low responsive aryl hydrocarbon receptors. Environ Health Perspect 2009; 117 (9): 1414-1419.
50. Vogel CF, Matsumura F., Interaction of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) with induced adipocyte differentiation in mouse embryonic fibroblasts (MEFs) involves tyrosine kinase c-Src. Biochem Pharmacol Oct 1 2003; 66 (7): 1231-1244.
51. Phillips M, Enan E, Liu PC, Matsumura F., Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci Jan 1995; 108 (Pt 1): 395-402.
52. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA., Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect Jun 2008; 116 (6): 761-768.
53. Spalding KL, Arner E, Westermark PO, et al., Dynamics of fat cell turnover in humans. Nature Jun 5 2008; 453 (7196): 783-787.
54. Arner P, Spalding KL., Fat cell turnover in humans. Biochem Biophys Res Commun May 21 2010; 396 (1): 101-104.
55. Kopec AK, Burgoon LD, Ibrahim-Aibo D, et al., Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice. Toxicol Sci Nov 2010; 118 (1): 286-297.
56. Branchi I, Alleva E, Costa LG., Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. Neurotoxicology Sep 2002; 23 (3): 375-384.
57. DeLong GT, Rice CD., Tributyltin potentiates 3,3',4,4',5- pentachlorobiphenyl-induced cytochrome P-4501A-related activity. J Toxicol Environ Health Jun 6 1997; 51 (2): 131-148.
58. Gladen BC, Klebanoff MA, Hediger ML, et al., Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect Dec 2004; 112 (17): 1761-1767.
59. Mendez MA, Garcia-Esteban R, Guxens M, et al., Prenatal Organochlorine Compound Exposure, Rapid Weight Gain and Overweight in Infancy. Environ Health Perspect Oct 5 2010.
60. Smink A, Ribas-Fito N, Garcia R, et al., Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr Oct 2008; 97 (10): 1465-1469.
61. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR, Jr,. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care Mar 2007; 30 (3): 622-628.
62. Lee SA, Dai Q, Zheng W, et al., Association of serum concentration of organochlorine pesticides with dietary intake and other lifestyle factors among urban Chinese women. Environ Int Feb 2007; 33 (2): 157-163.
63. Perry MJ, Ouyang F, Korrick S, et al., Body mass index and serum 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane in nulliparous Chinese women. Cancer Epidemiol Biomarkers Prev Oct 2005; 14 (10): 2433-2438.
64. Arnold DL, Moodie CA, Charbonneau SM, et al., Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A. Food Chem Toxicol Sep 1985; 23 (9): 779-793.
65. Randi AS, Sancovich HA, Ferramola de Sancovich AM, et al., Effect of in vivo administered hexachlorobenzene on epidermal growth factor receptor levels, protein tyrosine kinase activity, and phosphotyrosine content in rat liver. Biochem Pharmacol May 1 2003; 65 (9): 1495-1506.
66. Alvarez L, Randi A, Alvarez P, et al., Reproductive effects of hexachlorobenzene in female rats. J Appl Toxicol Jan-Feb 2000; 20 (1): 81-87.
67. Palanza P, Parmigiani S, vom Saal FS,. Effects of prenatal exposure to low doses of diethylstilbestrol, o,p'DDT, and methoxychlor on postnatal growth and neurobehavioral development in male and female mice. Horm Behav Sep 2001; 40 (2): 252-265.
68. Makita Y, Omura M, Tanaka A, Kiyohara C., Effects of concurrent exposure to tributyltin and 1,1-dichloro-2,2 bis (p-chlorophenyl) ethylene (p,p'-DDE) on immature male Wistar rats. Basic Clin Pharmacol Toxicol Dec 2005; 97 (6): 364-368.
69. Makita Y, Tanaka A, Omura M, Ogata R., Effects of simultaneous administration of tributyltin (TBT) and p,p(')-DDE on female offspring of Wistar rats. J Toxicol Environ Health A Dec 26 2003; 66 (24): 2337-2347.
70. Bell JU, Hansell MM, Ecobichon DJ., The influence of DDT on the ontogenesis of drug-metabolizing enzymes in the perinatal rat. Toxicol Appl Pharmacol Jan 1976; 35 (1): 165-177.
71. Ozcan U, Cao Q, Yilmaz E, et al., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science Oct 15 2004; 306 (5695): 457-461.
72. Gregor MF, Yang L, Fabbrini E, et al., Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes Mar 2009; 58 (3): 693-700.
73. Sanyal S, Agarwal N, Dudeja PK, Mahmood A, Subrahmanyam D., Effect of a single oral dose of DDT on lipid metabolism in protein-calorie malnourished monkeys. Indian J Biochem Biophys Apr 1982; 19 (2): 111-114.
74. Sanyal S, Agarwal N, Subrahmanyam D., Effect of acute sublethal and chronic administration of DDT (chlorophenotane) on brain lipid metabolism of rhesus monkeys. Toxicol Lett Nov 1986; 34 (1): 47-54.
75. Van den Heuvela F,. Decomposition analysis of differential dose volume histograms. Med Phys Feb 2006; 33 (2): 297-307.
76. Rosen MB, Lee JS, Ren H, et al., Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol Sci May 2008; 103 (1): 46-56.
77. Feige JN, Gerber A, Casals-Casas C, et al., The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ Health Perspect Feb 2010; 118 (2): 234-241.
78. Nelson JW, Hatch EE, Webster TF., Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ Health Perspect Feb 2010; 118 (2): 197-202.
79. Lin CY, Chen PC, Lin YC, Lin LY., Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care Apr 2009; 32 (4): 702-707.
80. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS., Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect May 2010; 118 (5): 686-692.
81. Fei C, McLaughlin JK, Tarone RE, Olsen J., Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect Nov 2007; 115 (11): 1677-1682.
82. Apelberg BJ, Witter FR, Herbstman JB, et al., Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect Nov 2007; 115 (11): 1670-1676.
83. Yang C, Tan YS, Harkema JR, Haslam SZ., Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol Jun 2009; 27 (3-4): 299-306.
84. Wolf CJ, Fenton SE, Schmid JE, et al., Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci Feb 2007; 95 (2): 462-473.
85. Perez-Maldonado IN, Ramirez-Jimenez Mdel R, Martinez-Arevalo LP, et al., Exposure assessment of polybrominated diphenyl ethers (PBDEs) in Mexican children. Chemosphere May 2009; 75 (9): 1215-1220.
86. Athanasiadou M, Cuadra SN, Marsh G, Bergman A, Jakobsson K., Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua. Environ Health Perspect Mar 2008; 116 (3): 400-408.
87. Fischer D, Hooper K, Athanasiadou M, Athanassiadis I, Bergman A., Children show highest levels of polybrominated diphenyl ethers in a California family of four: a case study. Environ Health Perspect Oct 2006; 114 (10): 1581-1584.
88. Toms LM, Sjodin A, Harden F, et al., Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2-5 years of age) than in infants and adults. Environ Health Perspect Sep 2009; 117 (9): 1461-1465.
89. Toms LM, Harden F, Paepke O, Hobson P, Ryan JJ, Mueller JF., Higher accumulation of polybrominated diphenyl ethers in infants than in adults. Environ Sci Technol Oct 1 2008; 42 (19): 7510-7515.
90. DiGangi J, Blum A, Bergman A, et al., San Antonio statement on brominated and chlorinated flame retardants. Environ Health Perspect 2010; 118: A516-A518.
91. Frederiksen M, Thomsen M, Vorkamp K, Knudsen LE., Patterns and concentration levels of polybrominated diphenyl ethers (PBDEs) in placental tissue of women in Denmark. Chemosphere Sep 2009; 76 (11): 1464-1469.
92. Daniels JL, Pan IJ, Jones R, et al., Individual Characteristics Associated with PBDE Levels in U.S. Human Milk Samples. Environ Health Perspect Jan; 118 (1): 155-160.
93. Gee JR, Moser VC., Acute postnatal exposure to brominated diphenylether 47 delays neuromotor ontogeny and alters motor activity in mice. Neurotoxicol Teratol Mar-Apr 2008; 30 (2): 79-87.
94. Fernie KJ, Laird Shutt J, Ritchie IJ, Letcher RJ, Drouillard K, Bird DM., Changes in the growth, but not the survival, of American kestrels (Falco sparverius) exposed to environmentally relevant polybrominated diphenyl ethers. J Toxicol Environ Health A Aug 2006; 69 (16): 1541-1554.
95. Suvorov A, Battista MC, Takser L., Perinatal exposure to low-dose 2,2',4,4'-tetrabromodiphenyl ether affects growth in rat offspring: what is the role of IGF-1? Toxicology Jun 16 2009; 260 (1-3): 126-131.
96. Hoppe AA, Carey GB., Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring) Dec 2007; 15 (12): 2942-2950.
97. Key PB, Chung KW, Hoguet J, Shaddrix B, Fulton MH,. Toxicity and physiological effects of brominated flame retardant PBDE-47 on two life stages of grass shrimp, Palaemonetes pugio. Sci Total Environ Jul 25 2008; 399 (1-3): 28-32.
98. Hatch EE, Nelson JW, Qureshi MM, et al., Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 2008; 7: 27.
99. Wolff MS, Teitelbaum SL, Windham G, et al., Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect Jan 2007; 115 (1): 116-121.
100. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH., Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect Jun 2007; 115 (6): 876-882.
101. Feige JN, Gelman L, Rossi D, et al., The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem Jun 29 2007; 282 (26): 19152-19166.
102. Hurst CH, Waxman DJ., Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci Aug 2003; 74 (2): 297-308.
103. Sargis RM, Johnson DN, Choudhury RA, Brady MJ., Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) Jul 2010; 18 (7): 1283-1288.
104. Poon R, Lecavalier P, Mueller R, Valli VE, Procter BG, Chu I., Subchronic oral toxicity of di-n-octyl phthalate and di(2-Ethylhexyl) phthalate in the rat. Food Chem Toxicol Feb 1997; 35 (2): 225-239.
105. Stein MS, Caasi PI, Nair PP., Influence of dietary fat and di-2-ethylhexyl phthalate on tissue lipids in rats. J Nutr Feb 1974; 104 (2): 187-191.
106. Wang YF, Chao HR, Wu CH, Tseng CH, Kuo YT, Tsou TC., A recombinant peroxisome proliferator response element-driven luciferase assay for evaluation of potential environmental obesogens. Biotechnol Lett Jul 28 2010.
107. Bishop-Bailey HD, Hla T, Warner TD,. Bisphenol A diglycidyl ether (BADGE) is a PPAR gamma agonist in an ECV304 cell line. Brit J Pharm 2000; 131: 651-654.
108. Lang IA, Galloway TS, Scarlett A, et al., Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA Sep 17 2008; 300 (11): 1303-1310.
109. Richter CA, Birnbaum LS, Farabollini F, et al., In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol Aug-Sep 2007; 24 (2): 199-224.
110. Alonso-Magdalena P, Vieira E, Soriano S, et al., Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring. Environ Health Perspect Sep 2010; 118 (9): 1243-1250.
111. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ., Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology Jun 2010; 151 (6): 2603-2612.
112. Stump DG, Beck MJ, Radovsky A, et al., Developmental neurotoxicity study of dietary bisphenol A in Sprague-Dawley rats. Toxicol Sci May 2010; 115 (1): 167-182.
113. Nakamura D, Yanagiba Y, Duan Z, et al., Bisphenol A may cause testosterone reduction by adversely affecting both testis and pituitary systems similar to estradiol. Toxicol Lett Apr 15 2010; 194 (1-2): 16-25.
114. Takai Y, Tsutsumi O, Ikezuki Y, et al., Estrogen receptor-mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem Biophys Res Commun Apr 21 2000; 270 (3): 918-921.
115. Takai Y, Tsutsumi O, Ikezuki Y, et al., Preimplantation exposure to bisphenol A advances postnatal development. Reprod Toxicol Jan-Feb 2001; 15 (1): 71-74.
116. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K., Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci Apr 2005; 84 (2): 319-327.
117. Masuno H, Kidani T, Sekiya K, et al., Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res May 2002; 43 (5): 676-684.
118. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J., Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway. Mol Pharmacol Mar 2005; 67 (3): 766-774.
119. Grun F, Watanabe H, Zamanian Z, et al., Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol Sep 2006; 20 (9): 2141-2155.
120. Grote K, Hobler C, Andrade AJ, et al., Effects of in utero and lactational exposure to triphenyltin chloride on pregnancy outcome and postnatal development in rat offspring. Toxicology Sep 5 2007; 238 (2-3): 177-185.
121. Delgado IF, Viana VG, Sarpa M, Paumgartten FJ., Postnatal development and resistance to Plasmodium yoelii infection of mice prenatally exposed to triphenyltin hydroxide. Environ Toxicol Dec 2009; 24 (6): 629-635.
122. Asakawa H, Tsunoda M, Kaido T, et al., Enhanced inhibitory effects of TBT chloride on the development of F1 rats. Arch Environ Contam Toxicol May 2010; 58 (4): 1065-1073.
123. Tsunoda M, Aizawa Y, Konno N, Kimura K, Sugita-Konishi Y., Subacute administration of tributyltin chloride modulates neurotransmitters and their metabolites in discrete brain regions of maternal mice and their F1 offspring. Toxicol Ind Health Feb 2006; 22 (1): 15-25.
124. Kirchner S, Kieu T, Chow C, Casey S, Blumberg B., Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol Mar 2010; 24 (3): 526-539.
125. Si J, Wu X, Wan C, et al., Peripubertal exposure to low doses of tributyltin chloride affects the homeostasis of serum T, E2, LH, and body weight of male mice. Environ Toxicol Jan 5 2010.
126. Zuo Z, Chen S, Wu T, et al., Tributyltin causes obesity and hepatic steatosis in male mice. Environ Toxicol Sep 16 2009.
127. Cooke GM, Tryphonas H, Pulido O, Caldwell D, Bondy GS, Forsyth D., Oral (gavage), in utero and postnatal exposure of Sprague-Dawley rats to low doses of tributyltin chloride. Part 1: Toxicology, histopathology and clinical chemistry. Food Chem Toxicol Feb 2004; 42 (2): 211-220.
128. Inadera H, Shimomura A., Environmental chemical tributyltin augments adipocyte differentiation. Toxicol Lett Dec 15 2005; 159 (3): 226-234.
129. Kim R, Hu H, Rotnitzky A, Bellinger D, Needleman H., A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect Oct 1995; 103 (10): 952-957.
130. Hu H, Rabinowitz M, Smith D., Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect Jan 1998; 106 (1): 1-8.
131. Huzior-Balajewicz A, Pietrzyk JJ, Schlegel-Zawadzka M, Piatkowska E, Zachwieja Z., The influence of lead and cadmium environmental pollution on anthropometric health factors in children. Przegl Lek 2001; 58 (4): 315-324.
132. Ronco AM, Gutierrez Y, Gras N, Munoz L, Salazar G, Llanos MN., Lead and arsenic levels in women with different body mass composition. Biol Trace Elem Res Sep 2010; 136 (3): 269-278.
133. Park SK, Schwartz J, Weisskopf M, et al., Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA Normative Aging Study. Environ Health Perspect Nov 2006; 114 (11): 1718-1724.
134. Leasure JL, Giddabasappa A, Chaney S, et al., Low-level human equivalent gestational lead exposure produces sex-specific motor and coordination abnormalities and late-onset obesity in year-old mice. Environ Health Perspect Mar 2008; 116 (3): 355-361.
135. von Kries R, Bolte G, Baghi L, Toschke AM., Parental smoking and childhood obesity - is maternal smoking in pregnancy the critical exposure? Int J Epidemiol Feb 2008; 37 (1): 210-216.
136. Toschke AM, Montgomery SM, Pfeiffer U, von Kries R., Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol Dec 1 2003; 158 (11): 1068-1074.
137. Syme C, Abrahamowicz M, Mahboubi A, et al., Prenatal exposure to maternal cigarette smoking and accumulation of intra-abdominal fat during adolescence. Obesity (Silver Spring) May 2010; 18 (5): 1021-1025.
138. Ng SP, Conklin DJ, Bhatnagar A, Bolanowski DD, Lyon J, Zelikoff JT., Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring. Environ Health Perspect Jul 2009; 117 (7): 1042-1048.
139. Somm E, Schwitzgebel VM, Vauthay DM, et al., Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology Dec 2008; 149 (12): 6289-6299.
140. Irigaray P, Ogier V, Jacquenet S, et al., Benzo[a]pyrene impairs beta-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. A novel molecular mechanism of toxicity for a common food pollutant. FEBS J Apr 2006; 273 (7): 1362-1372.
141. Tsukue N, Kato A, Ito T, Sugiyama G, Nakajima T., Acute effects of diesel emission from the urea selective catalytic reduction engine system on male rats. Inhal Toxicol Mar 2010; 22 (4): 309-320.
142. Shimada T, Hiramatsu N, Hayakawa K, et al., Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress. Am J Physiol Endocrinol Metab Apr 2009; 296 (4): E721-730.
143. Newbold RR, Padilla-Banks E, Jefferson WN., Environmental estrogens and obesity. Mol Cell Endocrinol May 25 2009; 304 (1-2): 84-89.
144. Newbold RR, Jefferson WN, Padilla-Banks E, Haseman J., Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects. Reprod Toxicol May 2004; 18 (3): 399-406.
145. Cagen SZ, Waechter JM, Jr,., Dimond SS, et al. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol Sci Jul 1999; 50 (1): 36-44.
146. Honma S, Suzuki A, Buchanan DL, Katsu Y, Watanabe H, Iguchi T., Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol Mar-Apr 2002; 16 (2): 117-122.
147. Ashby J, Tinwell H, Haseman J., Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol Oct 1999; 30 (2 Pt 1): 156-166.
148. Gupta C., Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exp Biol Med Jun 2000; 224 (2): 61-68.
149. Nikaido Y, Yoshizawa K, Danbara N, et al., Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol Aug-Sep 2004; 18 (6): 803-811.
150. Miyawaki J, Sakayama K, Kato H, Yamamoto H, Masuno H., Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb Oct 2007; 14 (5): 245-252.
151. Olfson M, Blanco C, Liu L, Moreno C, Laje G., National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry Jun 2006; 63 (6): 679-685.
152. Correll CU., Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry 2008; 69 (Suppl 4): 26-36.
153. Walter G, DeLaroche A, Soh N, et al., Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australas Psychiatry Aug 2008; 16 (4): 253-262.
154. Ratzoni G, Gothelf D, Brand-Gothelf A, et al., Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry Mar 2002; 41 (3): 337-343.
155. McIntyre RS, Jerrell JM., Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med Oct 2008; 162 (10): 929-935.
156. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK., Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA Oct 28 2009; 302 (16): 1765-1773.
157. Mishra AC, Mohanty B., Effect of lactational exposure of olanzapine on body weight of mice: a comparative study on neonates of both the sexes during post-natal development. J Psychopharmacol Jul 2010; 24 (7): 1089-1096.
158. Fell MJ, Neill JC, Rao C, Marshall KM., Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology (Berl) Nov 2005; 182 (4): 499-507.
159. Maayan L, Vakhrusheva J, Correll CU., Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis. Neuropsychopharmacology Jun 2010; 35 (7): 1520-1530.
160. Larsen TM, Toubro S, Astrup A., PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord Feb 2003; 27 (2): 147-161.
161. Musso G, Gambino R, Cassader M, Pagano G., A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology Jul 2010; 52 (1): 79-104.
162. Rubenstrunk A, Hanf R, Hum DW, Fruchart JC, Staels B., Safety issues and prospects for future generations of PPAR modulators. Biochim Biophys Acta Aug 2007; 1771 (8): 1065-1081.
163. Zdravkovic V, Hamilton JK, Daneman D, Cummings EA., Pioglitazone as
164. Stone ML, Walker JL, Chisholm D, et al., The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial. Pediatr Diabetes Jul 28 2008; 9 (4 Pt 1): 326-334.
165. Szocs Z, Brunmair B, Stadlbauer K, et al., Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats. J Pharmacol Exp Ther Jul 2008; 326 (1): 323-329.
166. Garg M, Thamotharan M, Pan G, Lee PW, Devaskar SU,. Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist. Am J Physiol Endocrinol Metab Mar 2010; 298 (3): E489-498.
167. Sato K, Matsushita K, Matsubara Y, Kamada T, Akiba Y., Adipose tissue fat accumulation is reduced by a single intraperitoneal injection of peroxisome proliferator-activated receptor gamma agonist when given to newly hatched chicks. Poult Sci Nov 2008; 87 (11): 2281-2286.
168. Sevillano J, Lopez-Perez IC, Herrera E, Del Pilar Ramos M, Bocos C. Englitazone administration to late pregnant rats produces delayed body growth and insulin resistance in their fetuses and neonates. Biochem J Aug 1 2005; 389 (Pt 3): 913-918.
169. Kroeze WK, Hufeisen SJ, Popadak BA, et al., H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology Mar 2003; 28 (3): 519-526.
170. Templeman LA, Reynolds GP, Arranz B, San L., Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics Apr 2005; 15 (4): 195-200.
171. Ellinger LK, Ipema HJ, Stachnik JM., Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain. Ann Pharmacother Apr 2010; 44 (4): 668-679.
172. Eskenazi B, Chevrier J, Rosas LG, et al., The Pine River statement: human health consequences of DDT use. Environ Health Perspect Sep 2009; 117 (9): 1359-1367.
173. La Merrill M, Harper R, Birnbaum LS, Cardiff RD, Threadgill DW., Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice. Environ Health Perspect May 2010; 118 (5): 596-601.
174. Fujiyoshi PT, Michalek JE, Matsumura F., Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect Nov 2006; 114 (11): 1677-1683.
175. Lee DH, Steffes MW, Jacobs DR, Jr,. Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia Mar 2008; 51 (3): 402-407.
176. Lassiter TL, Ryde IT, Mackillop EA, et al., Exposure of neonatal rats to parathion elicits sex-selective reprogramming of metabolism and alters the response to a high-fat diet in adulthood. Environ Health Perspect Nov 2008; 116 (11): 1456-1462.
177. Tuomisto JT, Pohjanvirta R, Unkila M, Tuomisto J., TCDD-induced anorexia and wasting syndrome in rats: effects of diet-induced obesity and nutrition. Pharmacol Biochem Behav Apr 1999; 62 (4): 735-742.
178. Shi H, Seeley RJ, Clegg DJ., Sexual differences in the control of energy homeostasis. Front Neuroendocrinol Aug 2009; 30 (3): 396-404.
179. Marti-Cid R, Bocio A, Llobet JM, Domingo JL., Intake of chemical contaminants through fish and seafood consumption by children of Catalonia, Spain: health risks. Food Chem Toxicol Oct 2007; 45 (10): 1968-1974.
180. LaKind JS, Amina Wilkins A, Berlin CM, Jr,. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol Jul 15 2004; 198 (2): 184-208.
181. Goldman LR, Harnly M, Flattery J, Patterson DGJ, Needham LL., Serum polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans among people eating contaminated home-produced eggs and beef. Environ Health Perspect 2000; 108 13-19.
182. Dewailly E, Ryan JJ, Laliberte C, et al., Exposure of remote maritime populations to coplanar PCBs. Environ Health Perspect Jan 1994; 102 (Suppl 1): 205-209.
183. Kabuto H, Amakawa M, Shishibori T., Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. Life Sci Apr 30 2004; 74 (24): 2931-2940.
184. Ryan BC, Vandenbergh JG., Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm Behav Jun 2006; 50 (1): 85-93.
185. Markey CM, Coombs MA, Sonnenschein C, Soto AM., Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev Jan-Feb 2003; 5 (1): 67-75.
186. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature Oct 21 1999; 401 (6755): 763-764.
187. Akingbemi BT, Sottas CM, Koulova AI, Klinefelter GR, Hardy MP., Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology Feb 2004; 145 (2): 592-603.
188. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM., Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect Jul 2001; 109 (7): 675-680.
189. Ishido M, Masuo Y, Kunimoto M, Oka S, Morita M., Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurosci Res May 1 2004; 76 (3): 423-433.